Cite
HARVARD Citation
Zeitoun, J. et al. (2016). Regulatory anticipation of postmarket safety problems for novel medicines approved by the EMA between 2001 and 2010: a cross‐sectional study. Pharmacoepidemiology and drug safety. 25 (6), pp. 687-694. [Online].